Ovarian Cancer Therapy: Homologous Recombination Deficiency as a Predictive Biomarker of Response to PARP Inhibitors

Miller RE, Elyashiv O, El-Shakankery KH, Ledermann JA

OncoTargets and Therapy 2022, 15:1105-1117

Published Date: 4 October 2022